The valuer general has knocked arguments by developer WSTI Properties in a High Court dispute over a heritage property in Melbourne, saying the contentions are “unavailable and unsound”.
EPC Pacific is facing a fight after it got the go-ahead from Yarra City Council to build an 11-storey mixed use office building in an inner city Melbourne suburb.
Otsuka Pharmaceuticals is challenging a decision revoking its patent for an injectable version of antipsychotic drug Abilify.
The High Court has been asked to overturn a ruling that found India was immune from a suit seeking to enforce a $111.3 million arbitral award because it did not involve a ‘commercial’ matter.
A former capital partner of HWL Ebsworth wants the High Court to overturn a finding that he was validly expelled from the partnership, arguing the firm’s conduct breached the Equal Opportunity Act.
Munich Reinsurance has been given the OK to bring additional claims in its $696 million lawsuit, which accuses AMP of misleading or deceptive conduct over a quota share agreement.
Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.
Canberra developer Geocon has filed a legal challenge seeking a tax refund on sales from a development for 360 residential units.
An appeals court has found water infrastructure investor Conexa liable to pay land duty on a $46 million Sydney pipeline it acquired as part of a blockbuster deal with Rosehill.
An appeals court has tossed a challenge to a judge’s decision that found a property developer was required to return a $1.3 million loan, despite finding the judge erred in holding enforceable an agreement reached over email.